In the spirit of reconciliation, Australian Associated Press acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our ...
Outsourcing Facilities Association and North American Custom Laboratories allege the FDA removed semaglutide from its ...
New diabetes medications are pressuring Medicare Part D financially as they drive up prescription drug costs amid rising ...
Novavax (NVAX) reported a large fourth quarter sales decline Thursday — and said it no longer wants to be known simply as a ...
AstraZeneca has opened a plant to produce biogas from organic waste that will ensure by the end of this year all of its ...
Novo Nordisk A/S, Apollo Global Management, BlackRock, Blackstone, Prologis, Welltower, and Ventas are the seven Growth ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...
Nutrition supplement maker Glanbia announced plans to sell its underperforming U.S. weight management brand SlimFast on ...
Drug compounders aren’t ready to give up their ability to produce off-brand versions of Novo Nordisk’s weight-loss drug ...
Today we'll look at six European stocks that could continue outperforming in 2025. Some of these companies are available to ...
The FDA recently removed semaglutide from its drug shortage list, which has not been considered commercially available since ...
As high prices and supply issues drive consumers to alternative markets for GLP-1s, physicians aren’t too interested in using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback